Curaleaf Holdings, Inc. (CURA) commenced trading on the Canadian Stock Exchange (CSE) on Monday October 29th, 2018, becoming the largest offering in terms of equity financing in the cannabis industry

Published On October 30, 2018 | By Clare Louise | Finance

A US cannabis retailer; Curaleaf raised close to CAD $520 million in a private placement fronted by GMP Securities L.P and Canaccord Genuity Corp. with assistance from Eight Capital, Haywood Securities Inc. and Cormark Securities Inc.

The Massachusetts based company, completed a reverse takeover of Canada’s Lead Ventures Inc. last week to earn an approximate CAD$6 billion valuation. 

Executive Chairman of Curaleaf, Boris Jordan said: “This is about a creating a currency we can use to keep acquiring businesses. We think there is going to be a huge consolidation – we’re going to move very quickly.”

With operations in 12 states, made up of 28 dispensaries, 12 cultivation facilities and nine processing sites; Curaleaf has wide spanning operations over the US. Licences have also been applied for in both California and Pennsylvania.

A US federal ban has created difficulties raising capital domestically; thus the legalisation of cannabis on a federal level in Canada has opened up a huge market for US companies looking to capitalise on the fast moving industry; with the CSE being the go-to market for public listings in the cannabis industry.

“Listing on the Canadian Securities Exchange is a critical step in our growth trajectory. We are excited to make our mark within cannabis financing history through the overwhelming support of over 100 institutions internationally,” explained CEO of Curaleaf, Joseph Lusardi.
“We remain committed to growing our business through aggressive organic growth and the strategic deployment of capital into accretive acquisitions that extend our brand into the most attractive US markets.”

Jacob Lee Cheung- Research analyst RBI Associates

Like this Article? Share it!

About The Author

Comments are closed.